Zoledronic acid prevents bone mineral density loss in premenopausal women receiving adjuvant treatment for hormone receptor-positive breast cancer: Preliminary results of a randomized, multicenter trial of zoledronic acid in patients receiving anastrozole or tamoxifen in combination with goserelin

✍ Scribed by H. Hausmaninger

• Book ID: 114315664
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 184 KB
• Volume: 12
• Category: Article
• ISSN: 0960-9776
• DOI: 10.1016/s0960-9776(03)80140-6